Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2022-03-01 (4 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOULOGNE-SUR-MER (62200), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PORTE NEUVE : revenue, balance sheet and financial ratios
PHARMACIE PORTE NEUVE is a French company
founded 4 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOULOGNE-SUR-MER (62200),
this company of category PME
shows in 2025 a net income negative of -10 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PORTE NEUVE (SIREN 910867464)
Indicator
2025
2024
2023
Revenue
N/C
N/C
N/C
Net income
-9 596 €
-44 €
47 634 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE PORTE NEUVE records a net loss of 10 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-9 596 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 614%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
614.446%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
9.956%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE PORTE NEUVE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
2025
Debt ratio
634.547
570.587
614.446
Financial autonomy
10.744
10.523
9.956
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
614.452025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch
In 2025, the debt ratio of PHARMACIE PORTE NEUVE (614.45) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
9.96%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE PORTE NEUVE (10.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 109.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
109.839
Liquidity indicators evolution PHARMACIE PORTE NEUVE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
2025
Liquidity ratio
197.061
134.232
109.839
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
109.842025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-31 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE PORTE NEUVE (109.84) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE PORTE NEUVE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PORTE NEUVE with other companies in the same sector:
Frequently asked questions about PHARMACIE PORTE NEUVE
What is the revenue of PHARMACIE PORTE NEUVE ?
The revenue of PHARMACIE PORTE NEUVE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE PORTE NEUVE profitable?
PHARMACIE PORTE NEUVE recorded a net loss in 2025.
Where is the headquarters of PHARMACIE PORTE NEUVE ?
The headquarters of PHARMACIE PORTE NEUVE is located in BOULOGNE-SUR-MER (62200), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE PORTE NEUVE ?
The tax return of PHARMACIE PORTE NEUVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PORTE NEUVE operate?
PHARMACIE PORTE NEUVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart